Heparin Market to Advance at CAGR of 6.8% During 2019-2027: TMR Report

• Demand for heparin drugs for treatment of various thrombotic events to steer revenue generation; availability of affordable heparin products especially to elderly patient population enriching heparin market prospects
• Need to reduce mortality of coagulation disorders in adults spurring demand; high prevalence of coronary heart disease and deep vein thrombosis in North America makes the region lucrative

WILMINGTON, Del., Aug. 26, 2022 /PRNewswire/ -- The heparin market size was pegged at US$ 10.8 Bn in 2018, reinforced by its abundant applications as anticoagulant in various clinical settings over the years. A scrutiny of recent heparin market trends indicate that launch of safer, cost-effective, and more efficacious heparin drugs has helped reduce prevalence of cardiovascular diseases (CVD). Of note, the products have grown in demand for treating coronary heart disease and deep vein thrombosis, found an in-depth heparin market revenue analysis.

The demand for anticoagulants including heparin has been growing in the patient populations for managing various lung, heart, and blood vessel, and heart diseases, notably in hospitals, which thus has enriched heparin market outlook considerably. Aside from increasing the affordability, stakeholders are also leaning on commercializing heparin products with less risks of the typical side effects. Stridently, the need has spurred R&D in low molecular weight heparin (LMWH), observed the study authors.

Get Exclusive PDF Sample Copy of Heparin Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803 

Key Findings of Heparin Market Study

• Rising Use in Various Indications of Thrombotic Events Propelling Product Sales: The mortality of coronary heart disease along with their risk factors has spurred the demand for various heparin products. Wide use of anticoagulant drugs in various indications have stirred lucrative opportunities which market players have tapped into over the past several years. Clinicians have been found to better manage major complication associated with heparin's use, such as bleeding, thereby positively impacted the demand in heparin market.
• Use of Heparin Drugs in Managing Coagulation Disorders Underpins Vast Profitable Avenue: Widespread need for anticoagulant therapies in various cardiovascular diseases and venous thromboembolism has reinforced potential revenues in heparin market. Affordability of heparin drugs and the fact that they have proved to be safe in the prevention and treatment of several thrombotic events are major propositions that have impelled the demand. High prevalence and rising incidence of atrial fibrillation in geriatric population have opened up enormous avenue for firms in the heparin market.

Heparin Market: Key Drivers

• Alarming prevalence of coronary heart disease in adults and their high mortality in developed regions are driving the use of heparin products in the patient population. The prevalence of other cardiovascular diseases has also risen in recent years, thus accelerating the demand for anticoagulant drugs.
• Rise in geriatric population in various countries is a key driver for the heparin market. Rising age is associated with risks of deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation.

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=803 

Heparin Market: Regional Growth Dynamics

• Rise in incidence and morbidity of coagulation disorders particularly venous thromboembolism (VTE) in Europe have propelled revenue streams in the regional market. Growing awareness of the mortality of those disorders will generate sizable lucrative opportunities in the Europe heparin market in the remaining years of the forecast period.
• North America held a major share of the global heparin market in 2019, and is estimated to remain lucrative in near future. Continuous R&D toward developing safer and cheaper products, coupled with massive support by regulatory agencies for their commercialization, has fueled revenue streams for players in the North America heparin market.

Heparin Market: Key Players

Prominent players in the heparin market include B. Braun, Baxter International Inc., Aspen, LEO Pharma A/S, Pfizer, Inc., Sanofi, Fresenius, and Dr. Reddy's Laboratories Ltd. Key players are adopting and implementing a mix of competitive strategies including collaborations, regulatory approvals, and developing of novel products.

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=803

Heparin Market Segmentation

Product

• Low Molecular Weight Heparin (LMWH)
• Ultra-low Molecular Weight Heparin (ULMWH)
• Unfractionated Heparin (UFH)

Source

• Bovine
• Porcine

Formulation

• Oral
• Parenteral

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Atrial Fibrillation Market: The global atrial fibrillation market is anticipated to exceed value of US$ 18.5 Bn by 2031 with a CAGR of 6% from 2022 to 2031.

Ostomy Drainage Bags Market: The global ostomy drainage bags market is expected to cross value of US$ 3.6 Bn by the end of 2031 with a CAGR of 5.4% from 2022 to 2031.

Biosimilars Market: The global biosimilars market is anticipated to reach more than US$ 85 Bn by the end of 2031 with a CAGR of 15.5% from 2022 to 2031.

Cat Allergy in Humans Market: The global cat allergy in humans market is anticipated to exceed US$ 7.8 Bn by 2031 with a CAGR of 6.3% from 2022 to 2031.

Dermal Filler Market: The dermal filler market in the U.S. is anticipated to reach US$ 3.3 Bn by the end of 2031 with a CAGR of 10.9% from 2022 to 2031.

Particle Therapy Market: The global particle therapy market is anticipated to exceed the value of US$ 1.2 Bn by 2031 with a CAGR of 8.6% from 2022 to 2031.

Physician Dispensed Cosmeceuticals Market: The global physician dispensed cosmeceuticals market is expected to reach the value of US$ 19 Bn by the end of 2031 with a CAGR of 7.8% from 2021 to 2031.

Hernia Repair Devices Market: The global hernia repair devices market is expected to reach the value of US$ 8.62 Bn by the end of 2028 with a CAGR of 6.9% from 2021 to 2028.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg